Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-07-19

Clinical Trial Update: Efficacy, Safety and Tolerability of Enteric-Coated Cholestyramine Capsules for Adult Short Bowel Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating enteric-coated cholestyramine capsules for adults with short bowel syndrome; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Enteric-coated cholestyramine capsules (cholestyramine)

Snippet

Sponsor: Pharmascience Inc. | Conditions: Short Bowel Syndrome | Phase 2 | Status: TERMINATED | Results posted: 2022-07-19